Medicare Enrolled
Dr. Julio Gutierrez, MD
Internal Medicine · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gutierrez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gutierrez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gutierrez
Dr. Julio Gutierrez is an internal medicine specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gutierrez performed 539 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gutierrez received a total of $837,214 from 47 pharmaceutical and/or device companies across 916 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gutierrez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 539 Medicare services
$837,214 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗539
Medicare services
Bottom 47% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$127
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
177 | $143 | $491 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
73 | $173 | $752 |
| New patient office visit, complex (60-74 min) | 49 | $170 | $598 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $97 | $269 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
47 | $143 | $520 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $100 | $350 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
28 | $87 | $324 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
18 | $27 | $106 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
17 | $27 | $88 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $132 | $453 |
| Ultrasound scan of organ tissue for measuring elasticity This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods. |
14 | $95 | $611 |
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
14 | $4 | $166 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$837,214
Total received (2018-2024)
Avg $119,602/year across 7 years
Top 0% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
916
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$135,598
2023
$101,908
2022
$140,108
2021
$76,947
2020
$54,680
2019
$192,236
2018
$135,737
Payments by company (2024)
Madrigal Pharmaceuticals
$53,665
Gilead Sciences, Inc.
$30,056
Exelixis Inc.
$23,461
Intercept Pharmaceuticals, Inc.
$17,880
ABBVIE INC.
$9,802
Takeda Pharmaceuticals U.S.A., Inc.
$191
Janssen Biotech, Inc.
$80
GENZYME CORPORATION
$66
Regeneron Healthcare Solutions, Inc.
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$51
Ipsen Biopharmaceuticals, Inc
$41
HISTOSONICS,INC.
$35
TerSera Therapeutics LLC
$35
Novo Nordisk Inc
$32
Eisai Inc.
$23
EVOKE PHARMA, INC.
$23
VIVUS LLC
$22
Stemline Therapeutics Inc.
$22
Lilly USA, LLC
$19
Merck Sharp & Dohme LLC
$18
RedHill Biopharma Inc.
$15
Top 3 companies account for 79.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$159,099
Gilead Sciences, Inc.
$144,259
Intercept Pharmaceuticals, Inc.
$121,888
INTERCEPT PHARMACEUTICALS, INC.
$102,773
Exelixis Inc.
$93,911
AbbVie Inc.
$56,481
Madrigal Pharmaceuticals
$53,665
ABBVIE INC.
$50,148
Alexion Pharmaceuticals, Inc.
$33,430
Regeneron Pharmaceuticals, Inc.
$15,240
FUJIFILM Medical Systems USA, Inc.
$1,675
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$723
Eisai Inc.
$563
EISAI INC.
$479
Takeda Pharmaceuticals U.S.A., Inc.
$474
FUJIFILM Wako Diagnostics U.S.A. Corporation
$341
Dova Pharmaceuticals
$311
AstraZeneca Pharmaceuticals LP
$262
Janssen Biotech, Inc.
$208
Alnylam Pharmaceuticals Inc.
$152
Boston Scientific Corporation
$135
E.R. Squibb & Sons, L.L.C.
$133
GENZYME CORPORATION
$96
Regeneron Healthcare Solutions, Inc.
$79
FUJIFILM Healthcare Americas Corporation
$65
VIVUS LLC
$58
Lilly USA, LLC
$54
Echosens North America, Inc.
$47
Novo Nordisk Inc
$46
Ipsen Biopharmaceuticals, Inc
$41
HISTOSONICS,INC.
$35
TerSera Therapeutics LLC
$35
INTRA-SANA LABORATORIES
$35
Shionogi Inc
$29
Spark Therapeutics, Inc.
$27
Merck Sharp & Dohme Corporation
$23
EVOKE PHARMA, INC.
$23
Rigel Pharmaceuticals, Inc.
$22
Stemline Therapeutics Inc.
$22
Blueprint Medicines Corporation
$21
Merck Sharp & Dohme LLC
$18
Medtronic Vascular, Inc.
$17
Dynavax Technologies Corporation
$16
Paratek Pharmaceuticals, Inc.
$15
RedHill Biopharma Inc.
$15
Foundation Medicine, Inc.
$15
Celgene Corporation
$14
Top 3 companies account for 50.8% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · CABOMETYX · CREON · Cabometyx · DUPIXENT · Doptelet · ELZONRIS · ENTYVIO · Epclusa · FASENRA · FibroScan · GATTEX · GAVRETO · GIMOTI · GIVLAARI · Harvoni · Heplisav-B · IMBRUVICA · IMFINZI · IQIRVO · KANUMA · KEYTRUDA · Kanuma · LINZESS · LIVTENCITY · LOKELMA · Lenvima · MAVYRET · Mavyret · Micra · Mulpleta · NUZYRA · OCALIVA · OPDIVO · Ozempic · PREVYMIS · QSYMIA · RELTONE 200 MG · RESMETIROM · REZDIFFRA · RINVOQ · STELARA · TRULANCE · Talicia · Tavalisse · UTASWAKO AFP-L3 · VERZENIO · Wako HCC Biomarker(s) DCP and AFP-L3 · XIFAXAN · XIFIXAN · Xermelo · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
5,219
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.9 mi
0.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gutierrez is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gutierrez experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Gutierrez performed 177 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gutierrez receive payments from pharmaceutical companies?
Yes. Dr. Gutierrez received a total of $837,214 from 47 companies across 916 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gutierrez's costs compare to other internal medicine physicians in Los Angeles?
Dr. Gutierrez's average Medicare payment per service is $127. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gutierrez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Los Angeles
Browse internal medicine physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Intercept Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Intercept Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology